Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Educational Training Program

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Active Not Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07122960Not ApplicableActive Not RecruitingPrimary

Strengthening Informed Consent for Authentic Participation in Perinatal HIV Research

NCT03992664Not ApplicableCompletedPrimary

Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.

Showing all 2 trials

Research Network

Common Treatments

  • Educational Training Program1
  • Visual Icf1
  • Textonly Icf1

Active Sponsors

  • University of Stellenbosch1
  • Cyprus University of Technology1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
  • Columbia University1

Top Investigators

Related Conditions

  • Lung Cancer1
  • Head And Neck Cancer1
  • Pancreas Cancer1
  • Colon Cancer1
  • Breast Cancer1

Activity Timeline